The up-regulation of the expression of cell cycle genes in aggressive neuroblastoma tumours was already observed by Krasnoselsky et al. [26] in a comparison of tumours of different stages and MYCN amplification status, where patient outcome was not regarded. This evidence concerns the gene MYCN and neuroblastoma.